Skip to main content
logo
Hanx Biopharmaceuticals (Wuhan) Co., Ltd. (HKG:3378)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
28.56
+1.00 (3.63%)
Jul 31, 2026, 4:08 PM HKT

HKG:3378 Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023
Period EndingDec '25 Dec '25 Dec '24 Dec '23
Revenue
0.090.092.22.54
Revenue Growth
--95.82%-13.39%-
Gross Profit
0.090.092.22.54
Operating Income
-145.14-145.14-118.71-61.34
Net Income
-131.01-131.01-115.83-76.06
Earnings Per Share
-1.11-1.11-0.98-10.42
EPS Growth
----

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023
Period EndingDec '25 Dec '25 Dec '24 Dec '23
Cash & Investments
652.17652.17173.88204.36
Total Debt
55.8655.8611.8315.03
Net Cash (Debt)
596.3596.3162.05189.33
Net Cash Growth
-267.98%-14.41%-
Net Cash Per Share
5.045.041.3725.95

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023
Period EndingDec '25 Dec '25 Dec '24 Dec '23
Operating Cash Flow
-102.38-102.38-104.89-51.99
Capital Expenditures
-1.84-1.84-6.21-4.23
Free Cash Flow
-104.22-104.22-111.1-56.23
Free Cash Flow Growth
----

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023
Period EndingDec '25 Dec '25 Dec '24 Dec '23
Gross Margin
100.00%100.00%100.00%100.00%
Operating Margin
-157764.13%-157764.13%-5398.55%-2416.07%
Pretax Margin
-157647.83%-157647.83%-5585.27%-3679.52%
Profit Margin
-142398.91%-142398.91%-5267.39%-2995.51%
FCF Margin
-113280.44%-113280.44%-5052.48%-2214.49%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023
Period EndingAug '26 Dec '25 Dec '24 Dec '23
PS Ratio
38000.0821262.04--